Genomics at cellular resolution: insights into cognitive disorders and their evolution

Area of Science:

• Genomics
• Neuroscience
• Evolutionary Biology

Background:

• High-throughput genomic sequencing offers insights into cognitive disorders like autism, schizophrenia, and Alzheimer's disease.
• Genetic complexity of these disorders poses challenges for modeling in non-human systems.
• Human genome evolution and its impact on brain development are crucial for advancing disease models.

Purpose of the Study:

• To review studies assessing cell-type-specific gene expression in primate brains.
• To explore how specific cell types in the evolved human brain contribute to cognitive disorders.
• To highlight the role of non-neuronal cells, often underappreciated, in brain evolution and disease.

Main Methods:

• Analysis of cell-type-specific gene expression data across primate species.
• Comparison of gene expression profiles in healthy versus disease populations.
• Integration of genome-wide variant data with cell-type-specific expression and epigenetic information.

Main Results:

• Recent studies reveal cell-type-specific gene expression patterns in primate brains.
• Emerging findings link specific cell types in the evolved human brain to cognitive disorders.
• The role of non-neuronal cells in brain evolution and cognitive disorders is increasingly recognized.

Conclusions:

• Cell-type-specific analyses are key to understanding the genetic basis of cognitive disorders.
• Investigating the evolved human brain at a cellular level offers new avenues for therapeutic development.
• Further research integrating genomic, expression, and epigenetic data across cell types is warranted.